05.07.2007Advent Venture Partners and Partech International announce Pertinence merger with Intercim

Press Release
02.07.2007Biogen Idec and CardioKine partner to develop Lixivaptan, a novel Vasopressin Antagonist

Press Release
04.06.2007Algeta's Phase II Clinical Study Data for Alpharadin™ in Prostate Cancer Published in Lancet Oncology

Press Release
01.05.2007Advent Venture Partners announces the appointment of Dr Richard Mason to the Life Sciences team as Executive-in-Residence

Press Release
26.03.2007Advent Venture Partners' portfolio company Algeta raises NOK 250 million in successful offering

Algeta ASA, the Norwegian cancer therapeutics company, today announced the successful closing of its initial public offering.

Press Release
01.03.2007Advent Venture Partners invests in $175m financing round for EUSA Pharma Inc, new transatlantic specialty pharmaceutical company

Press Release
05.02.2007Speciality European Pharma completes two major acquisitions and closes first major financing round of Euro 15million from Advent Venture Partners

Press Release
01.02.2007Advent Ventures portfolio company Algeta applies for listing on the Oslo Stock Exchange

Algeta ASA, the Norwegian therapeutics company, today announced its application for listing on the Oslo Stock Exchange (Oslo Børs).

Press Release